您的位置: 首页 > 农业专利 > 详情页

Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
专利权人:
Regents of the University of Minnesota;HealthPartners Research & Education
发明人:
Daniel A. Wolf,William H. Frey, II,R. Scott McIvor,Leah R. Hanson
申请号:
US14103597
公开号:
US09249424B2
申请日:
2013.12.11
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The invention provides a method to prevent, inhibit or treat one or more neurological symptoms associated with a lysosomal storage disease in a mammal in need thereof, which includes intranasally administering to the mammal a composition comprising an effective amount of a lysosomal storage enzyme or a recombinant adeno-associated virus vector comprising an open reading frame encoding a lysosomal storage enzyme. Also provided are compositions and devices useful in the methods.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充